Astrana Health, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY September 30, 2022 |
|---|---|---|---|---|---|
| Revenue | $3.2B | $2.0B | $1.4B | $1.1B | — |
| Operating income | $78.5M | $89.3M | $84.6M | $104.3M | — |
| Cash from operations | $114.6M | $52.2M | $68.2M | $82.1M | — |
| Capital expenditure | $10.1M | $8.0M | $28.5M | $22.9M | — |
| Free cash flow | $104.5M | $44.2M | $39.7M | $59.2M | — |
| Share repurchases | $25.6M | $900,000 | $10.2M | $9.2M | — |
| Impairments | $0 | $0 | $0 | $0 | — |
| Total assets | $2.2B | $1.4B | $933.4M | $966.2M | $954.9M |
| Total liabilities | $1.7B | $840.7M | $522.6M | $407.7M | $410.4M |
| Total debt | $1.1B | $438.1M | $282.0M | $207.3M | — |
Shares outstanding 55.7M · Free float 52.8%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.